A comprehensive view of Prescription Drugs. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Elevance Health's CarelonRx launches SpecialtyRx Savings Navigator; the tool is designed to aid employers in planning for future speciality pharmacy costs while providing critical support to members with their health conditions
Published: April 26, 2024 by FierceHealthcare
Morgan Stanley expects ice cream to be most affected food category in light of GLP-1 drugs' popularity, with 5.3% dip in consumption by 2035; cakes, cookies, candies, chocolates, frozen pizzas, chips and regular sodas could fall by over 4% in this time
Published: April 26, 2024 by Green Queen
Pfizer gains FDA approval for its gene therapy Beqvez for hemophilia B treatment, pricing it at US$3.5M, matching the cost of the world's most expensive drug, Hemgenix; the therapy aims to provide long-term benefits and potentially reduce costs
Published: April 26, 2024 by FiercePharma
Executive Perspective: AstraZeneca CEO Pascal Soriot defends recent spate of acquisitions, arguing they're vital for future growth; Soriot says the deals aim to create synergy between oncology, vaccines, and respiratory disease products
Published: April 25, 2024 by FiercePharma
Merck's newly approved PAH treatment, Winrevair, forecast to reach sales of US$3.9B by 2029; the robust start to the drug's launch signals a significant boost for the company's future revenue with cancer drug Keytruda's patent expiry looming
Published: April 25, 2024 by FiercePharma

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count